CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2013—Life Technologies and RainTree Oncology Services have entered into a collaborative agreement designed to further the advancement of personalized care for cancer patients.
Through the collaboration, RainTree and Life Technologies will seek to make the latest advances in molecular testing available to the broader patient market and will work to develop a streamlined protocol for entering patients into clinical trials for new targeted therapies, using a next-generation sequencing oncology screening panel.
Additional elements of the collaboration include developing a clinical trials recruitment database; educating private payers about the benefits of next-generation sequencing; and building and marketing comprehensive product, test, and data offerings for clinical research organizations.
Life Technologies, 800-955-6288
RainTree Oncology Services, 858-436-7473